Schrodinger, Inc. Common Stock (SDGR) Stock Price

SDGRStock

$19.99−7.61%52W

Market Cap$1.50B

P/E—

PEG Ratio—

Div yield—

Beta1.68

SDGR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)47.69%

Price vs S&P 500 (4W)19.71%

VGM Score56.32

P/CF (Annual)98.84x

Book Value / Share (Quarterly)$4.40

P/TBV (Annual)4.70x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)12.23%

Cash Flow / Share (Quarterly)$-1.74

Price vs S&P 500 (YTD)-6.98%

Gross Margin (TTM)56.87%

Net Profit Margin (TTM)-20.98%

EPS (TTM)$-0.74

10-Day Avg Trading Volume1.12M

EPS Excl Extra (TTM)$-0.74

Revenue Growth (5Y)18.81%

EPS (Annual)$-1.41

ROI (Annual)-28.37%

Gross Margin (Annual)55.74%

Net Profit Margin (5Y Avg)-53.39%

Cash / Share (Quarterly)$5.53

Revenue Growth QoQ (YoY)7.54%

ROA (Last FY)-14.22%

Revenue Growth TTM (YoY)8.88%

EBITD / Share (TTM)$-1.99

ROE (5Y Avg)-23.34%

Operating Margin (TTM)-59.24%

Cash Flow / Share (Annual)$0.17

P/B Ratio4.18x

P/B Ratio (Quarterly)3.69x

Net Income / Employee (Annual)$-121,500

EV / Revenue (TTM)4.19x

Net Interest Coverage (TTM)-63.83x

ROA (TTM)-8.19%

EPS Incl Extra (Annual)$-1.41

Current Ratio (Annual)2.75x

Quick Ratio (Quarterly)2.65x

3-Month Avg Trading Volume1.34M

52-Week Price Return-7.61%

EV / Free Cash Flow (Annual)87.17x

Revenue / Employee (TTM)$304,700

Tangible BV / Share (Quarterly)$7.60

P/S Ratio (Annual)5.37x

Asset Turnover (Annual)0.35x

52-Week High$23.02

Operating Margin (5Y Avg)-81.97%

EPS Excl Extra (Annual)$-1.41

CapEx CAGR (5Y)-10.71%

Tangible BV CAGR (5Y)64.36%

26-Week Price Return58.93%

Quick Ratio (Annual)2.68x

13-Week Price Return41.87%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.71x

Enterprise Value$1.09B

Revenue / Share Growth (5Y)14.10%

Asset Turnover (TTM)0.39x

Book Value / Share Growth (5Y)-11.16%

Revenue / Employee (Annual)$301,000

Pretax Margin (Annual)-39.99%

Cash / Share (Annual)$5.37

3-Month Return Std Dev58.38%

Gross Margin (5Y Avg)57.54%

Net Income / Employee (TTM)$-63,900

ROE (Last FY)-28.37%

Net Interest Coverage (Annual)-3.42x

EPS Basic Excl Extra (Annual)$-1.41

Receivables Turnover (TTM)6.66x

EV / Free Cash Flow (TTM)46.68x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.74

Receivables Turnover (Annual)1.44x

ROI (TTM)-16.37%

P/S Ratio (TTM)5.30x

Pretax Margin (5Y Avg)-53.03%

Revenue / Share (Annual)$3.48

Tangible BV / Share (Annual)$7.60

Free OCF CAGR (5Y)-2.61%

Price vs S&P 500 (52W)-25.92%

Year-to-Date Return4.98%

5-Day Price Return6.23%

EPS Normalized (Annual)$-1.41

ROA (5Y Avg)-13.36%

Net Profit Margin (Annual)-40.36%

Month-to-Date Return23.98%

Cash Flow / Share (TTM)$0.68

EBITD / Share (Annual)$-2.19

Operating Margin (Annual)-65.23%

P/CF (TTM)69.74x

ROI (5Y Avg)-23.34%

EPS Basic Excl Extra (TTM)$-0.74

P/TBV (Quarterly)4.70x

P/B Ratio (Annual)3.62x

Pretax Margin (TTM)-20.05%

Book Value / Share (Annual)$4.94

Price vs S&P 500 (13W)39.08%

Beta1.68x

P/FCF (Annual)110.28x

Revenue / Share (TTM)$3.42

ROE (TTM)-16.37%

52-Week Low$10.95

vGradeC

gGradeC

mGradeB

vgmGradeC

SDGR Earnings Surprise History

Q2 25-0.65est. -0.64

Q3 25-0.57est. -0.74

Q4 25-0.18est. -0.09

Q1 26-0.62est. -0.57

Q2 26-0.42est. -0.67

SDGR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.07

4.00

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
SDGRSchrodinger, Inc. Common Stock	C	C	B	$19.99
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Schrodinger, Inc. Common Stock

Schrodinger is a software platform company that helps pharmaceutical, biotech, and materials science organizations accelerate molecular discovery and optimization. The company operates two segments: a Software segment that licenses its computational platform to enterprise customers (the primary revenue source), and a Drug Discovery segment that develops internal and collaborative preclinical and clinical programs. The United States represents the company's largest geographic market.